The Mechanism of Adaptation of Breast Cancer Cells to Hypoxia: Role of AMPK/mTOR Signaling Pathway


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We studied the mechanisms of adaptation of human breast cancer cells MCF-7 to hypoxia and analyzed the role of AMPK/mTOR signaling pathway in the maintenance of cell proliferation under hypoxic conditions. It was found that long-term culturing (30 days or more) of MCF-7 cells under hypoxic conditions induced their partial adaptation to hypoxia. Cell adaptation to hypoxia was associated with attenuation of hypoxia-dependent AMPK induction with simultaneous constitutive activation of mTOR and Akt. These findings suggest that these proteins can be promising targets for targeted therapy of tumors developing under hypoxic conditions.

Sobre autores

D. Sorokin

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: alex.scherbakov@gmail.com
Rússia, Moscow

A. Scherbakov

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: alex.scherbakov@gmail.com
Rússia, Moscow

I. Yakushina

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: alex.scherbakov@gmail.com
Rússia, Moscow

S. Semina

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: alex.scherbakov@gmail.com
Rússia, Moscow

M. Gudkova

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: alex.scherbakov@gmail.com
Rússia, Moscow

M. Krasil’nikov

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: alex.scherbakov@gmail.com
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media New York, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies